Pharmaco-economics and drug prices
Rutten, F.F.
Nederlands Tijdschrift Voor Geneeskunde 140(45): 2216-2219
1996
ISSN/ISBN: 0028-2162 PMID: 8984363 Document Number: 455495
Document emailed within 1 workday
Related Documents
Scheen, A.J.; Lefèbvre, P.J. 1998: Pharmaco-economics of type 2 diabetes Revue Medicale de Liege 53(5): 285-2892000: Pharmaco-economics of heart failure. The proper diuretic helps reduce costs MMW Fortschritte der Medizin 142(48): 67-68
Macdonald, R J. 2012: On the Role of Paradigms in Finance; From Economics Imperialism to Freakonomics: The Shifting Boundaries between Economics and Other Social Sciences; Economics Versus Human Rights Review of Social Economy 70(1): 134-141
Barbaud, A.; Tréchot, P.; Schmutz, J.L. 1997: Pharmaco-surveillance of drug-induced cutaneous accidents Annales de Dermatologie et de Venereologie 124(6-7): 474-475
Kelley, T. 2017: Drug Prices: Why So High and Why So #&*! Complicated Managed Care 26(12): 14-16
Lubell, J. 2010: Out is in; in is out. Reform law lowers drug prices--for outpatient only Modern Healthcare 40(18): 12-13
Goozner, M. 2016: The unaffordable cost of M&A-driven drug prices Modern Healthcare 46(35): 24
Huff, B. 2002: Patient care squeezed by soaring drug prices Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 16(4): 1-7
Danhof, M.; Visser, S.A. G. 2002: Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: focus on preclinical steps Methods and Findings in Experimental and Clinical Pharmacology 24 Suppl D: 127-128
Weissenstein, E. 1992: Senate proposal would reduce drug prices for federal agencies Modern Healthcare 22(33): 20
Castellucci, M. 2016: Taking the initiative in healthcare: will California voters cap drug prices? Modern Healthcare 46(43): 8; 10
Fong, T. 2004: Rules and regulations. CMS addresses drug prices, payment rates Modern Healthcare 34(31): 8-9 13
Greene, J. 2018: Why drug prices will continue to roil the waters-and why Scott Gottlieb, MD, will be in the center of the action Managed Care 27(12): 23-28
Herman, B. 2015: ACA coverage expansion at risk...battle against high drug prices...growing government business Modern Healthcare 45(1): 20
Babin, J.P.; Martin, C. 1986: Behavioral features of the fetus, the neonate and the infant caused by maternal neurotropic drug ingestion. Feto-infantile pharmaco and iatrogenic etiopathology Archives Francaises de Pediatrie 43(7): 517-523
Itil, T.M.; Marasa, J.; Bigelow, A.; Saletu, B. 1974: Prediction of neuroleptic effects of CI-686 based on quantitative pharmaco-electroencephalography: drug profiles and dose response curves based on computerized cerebral bio-potentials Current Therapeutic Research 16(1): 80-96
Jurista, J. 1979: Development and characteristics of scientific and research work of the department of economics and management of agriculture at the Bratislava School of Economics Zemedelska ekonomika 25(5): 365-368
Greenlick, M.R. 1974: The scope and bounds of health economics and medical economics Israel Journal of Medical Sciences 10(1): 81-95
Ahuja, M.M.; Buckshee, K.; Grover, J.K.; Ammini, A.C. 1983: Endocrine pharmaco-therapeutics Journal of the Association of Physicians of India 31(10): 655-656
Saletu, B. 1982: Pharmaco-EEG profiles of typical and atypical antidepressants Advances in Biochemical Psychopharmacology 32: 257-268